Investigating the Relationship of Serum CD163, YKL40 and VILIP-1 Levels with Autism Severity and Language-cognitive Development in Preschool Children with Autism

키워드

참고문헌 (63)

1. First MB, "DSM-5 handbook of differential diagnosis" (2013), American Psychiatric Publishing
2. Maenner MJ, "Prevalence of autism spectrum disorder among children aged 8 years—autism and developmental disabilities monitoring network, 11 sites, United States, 2016", MMWR Surveil Summ, 69, pp.1~12 (2020)
3. Eissa N, "Current enlightenment about etiology and pharmacological treatment of autism spectrum disorder", Front Neurosci, 12, pp.304~ (2018)
4. Paolicelli RC, "Function and dysfunction of microglia during brain development : consequences for synapses and neural circuits", Front Synaptic Neurosci, 9, pp.9~ (2017)
5. Özaslan A, "Increased serum level of CCL5 in children with attention‑deficit", hyperactivity disorder : first results about serum chemokines, 2022, pp.20, 109~117
6. Vargas DL, "Neuroglial activation and neuroinflammation in the brain of patients with autism", Ann Neurol, 57, pp.67~81 (2005)
7. Jensen AR, "Modern biomarkers for autism spectrum disorder : future directions", Mol Diagn Ther, 26, pp.483~495 (2022)
8. Shen L, "Biomarkers in autism spectrum disorders : current progress", Clin Chim Acta, 502, pp.41~54 (2020)
9. Liao X, "Microglia mediated neuroinflammation in autism spectrum disorder", J Psychiatr Res, 130, pp.167~176 (2020)
10. Møller HJ, "Identification of the hemoglobin scavenger receptor", CD163as a natural soluble protein in plasma, 2002, pp.99, 378~380
11. Prata J, "The contribution of inflammation to autism spectrum disorders : recent clinical evidence", Methods Mol Biol, 2011, pp.493~510 (2019)
12. Prata J, "Bridging Autism Spectrum Disorders and Schizophrenia through inflammation and biomarkers-pre-clinical and clinical investigations", J Neuroinflammation, 14, pp.179~ (2017)
13. Johansen JS, "Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer", Dan Med Bull, 53, pp.172~209 (2006)
14. Bonneh-Barkay D, "In vivo CHI3L1(YKL-40)expression in astrocytes in acute and chronic neurological diseases", J Neuroinflammation, 7, pp.34~ (2010)
15. Bonneh-Barkay D, "YKL-40 expression in traumatic brain injury : an initial analysis", J Neurotrauma, 27, pp.1215~1223 (2010)
16. Spilker C, "Calcium-myristoyl switch, subcellular localization, and calcium-dependent translocation of the neuronal calcium sensor protein VILIP-3, and comparison with VILIP-1 in hippocampal neurons", Mol Cell Neurosci, 24, pp.766~778 (2003)
17. Gierke P, "Implication of neuronal Ca2+-sensor protein VILIP-1 in the glutamate hypothesis of schizophrenia", Neurobiol Dis, 32, pp.162~175 (2008)
18. Dulewicz M, "Neurogranin and VILIP-1 as molecular indicators of neurodegeneration in alzheimer’s disease : a systematic review and meta-analysis", Int J Mol Sci, 21, pp.8335~ (2020)
19. Braunewell KH, "The visinin-like proteins VILIP-1 and VILIP-3in Alzheimer’s disease-old wine in new bottles", Front Mol Neurosci, 5, pp.20~ (2012)
20. Halbgebauer S, "Visinin-like protein 1 levels in blood and CSF as emerging markers for Alzheimer’s and other neurodegenerative diseases", Alzheimers Res Ther, 14, pp.175~ (2022)
21. Braunewell KH, "Association of VSNL1 with schizophrenia, frontal cortical function, and biological significance for its gene product as a modulator of cAMP levels and neuronal morphology", Transl Psychiatry, 1, pp.e22~ (2011)
22. Ayaydın H, "High serum levels of serum 100 beta protein, neuron-specific enolase, tau, active caspase-3, M30 and M65 in children with autism spectrum disorders", Clin Psychopharmacol Neurosci, 18, pp.270~278 (2020)
23. Matta SM, "The influence of neuroinflammation in Autism Spectrum Disorder", Brain Behav Immun, 79, pp.75~90 (2019)
24. Purves-Tyson TD, "Increased macrophages and C1qA, C3, C4 transcripts in the midbrain of people with schizophrenia", Front Immunol, 11, pp.2002~ (2020)
25. Wesseling H, "A combined metabonomic and proteomic approach identifies frontal cortex changes in a chronic phencyclidine rat model in relation to human schizophrenia brain pathology", Neuropsychopharmacology, 38, pp.2532~2544 (2013)
26. Rymo I, "CSF YKL-40 and GAP-43 are related to suicidal ideation in older women", Acta Psychiatr Scand, 135, pp.351~357 (2017)
27. Anderson AM, "Higher soluble CD163 in blood is associated with significant depression symptoms in men with HIV", J Acquir Immune Defic Syndr, 91, pp.325~333 (2022)
28. North H, "Discovering links between inflammation, neurogenesis, brain structure and brain function in schizophrenia", pp.2021
29. Schopler E, "The childhood autism rating scale, second edition (CARS2)" (2010), Western Psychological Services
30. Sucuoğlu B, "Otistik çocukların değerlendirilmesinde kullanılan ölçeklere ilişkin bir çalışma", Psikiyatri Psikoloji Psikofarmakoloji Dergisi, 4, pp.116~121 (1996)
31. Savasir I, "Handbook of Ankara developmental screening inventory" (1994), Turkish Psychologists Association Publication
32. Sezgin N, "Two different validity study of ankara developmental screening inventory (ADSI): criterion-related validity and concurrent discrimination validity", Turk J Child Adolesc Ment Health, 18, pp.185~196 (2011)
33. Volden J, "Using the preschool language scale, fourth edition to characterize language in preschoolers with autism spectrum disorders", Am J Speech Lang Pathol, 20, pp.200~208 (2011)
34. Zimmerman IL, "The role of a language scale for infant and preschool assessment", Ment Retard Dev Disabil Res Rev, 11, pp.238~246 (2005)
35. Yalçlnkaya F, "CBP02Turkish adaptation of speech and language disorders test: “Preschool Language Scale, fourth edition: PLS-4”", Eur J Paediatr Neurol, 11(Suppl 1), pp.87~ (2007)
36. Pey P, "Phenotypic profile of alternative activation marker CD163 is different in Alzheimer’s and Parkinson’s disease", Acta Neuropathol Commun, 2, pp.21~ (2014)
37. Nissen SK, "Soluble CD163 changes indicate monocyte association with cognitive deficits in Parkinson’s disease", Mov Disord, 36, pp.963~976 (2021)
38. Møller HJ, "Soluble CD163", Scand J Clin Lab Invest, 72, pp.1~13 (2012)
39. Møller HJ, "Plasma level of the macrophage-derived soluble CD163 is increased and positively correlates with severity in Gaucher’s disease", Eur J Haematol, 72, pp.135~139 (2004)
40. Greisen SR, "Soluble macrophage-derived CD163 is a marker of disease activity and progression in early rheumatoid arthritis", Clin Exp Rheumatol, 29, pp.689~692 (2011)
41. Magdalinou NK, "A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes", J Neurol Neurosurg Psychiatry, 86, pp.1240~1247 (2015)
42. Hall S, "Longitudinal measurements of cerebrospinal fluid biomarkers in Parkinson’s disease", Mov Disord, 31, pp.898~905 (2016)
43. Dichev V, "YKL-40 and neuron-specific enolase in neurodegeneration and neuroinflammation", Rev Neurosci, 31, pp.539~553 (2020)
44. Fagan AM, "Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer’s disease : a cross-sectional study", Lancet Neurol, 20, pp.615~626 (2021)
45. Bonneh-Barkay D, "YKL-40, a marker of simian immunodeficiency virus encephalitis, modulates the biological activity of basic fibroblast growth factor", Am J Pathol, 173, pp.130~143 (2008)
46. Lananna BV, "Chi3l1", YKL-40 is controlled by the astrocyte circadian clock and regulates neuroinflammation and Alzheimer’s disease pathogenesis, 2020, pp.12, eaax3519~
47. Villar-Piqué A, "Plasma YKL-40 in the spectrum of neurodegenerative dementia", J Neuroinflammation, 16, pp.145~ (2019)
48. Dieset I, "An association between YKL-40 and type 2 diabetes in psychotic disorders", Acta Psychiatr Scand, 139, pp.37~45 (2019)
49. Llorens F, "YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias", Mol Neurodegener, 12, pp.83~ (2017)
50. Chupp GL, "A chitinase-like protein in the lung and circulation of patients with severe asthma", N Engl J Med, 357, pp.2016~2027 (2007)
51. Kwon Y, "Serum YKL-40 levels are associated with the atherogenic index of plasma in children", Mediators Inflamm, 2020, pp.8713908~ (2020)
52. Pranzatelli MR, "Microglial", macrophage markers CHI3L1, sCD14, and sCD163 in CSF and serum of pediatric inflammatory and non-inflammatory neurological disorders : a case-control study and reference ranges, 2017, pp.381, 285~290
53. Qi Y, "Increased cerebrospinal fluid YKL-40 levels are associated with disease severity of neuromyelitis optica spectrum disorders", Mult Scler Relat Disord, 45, pp.102395~ (2020)
54. Wang WY, "Role of pro-inflammatory cytokines released from microglia in Alzheimer’s disease", Ann Transl Med, 3, pp.136~ (2015)
55. Vinther-Jensen T, "YKL-40 in cerebrospinal fluid in Huntington’s disease--a role in pathology or a nonspecific response to inflammation?", Parkinsonism Relat Disord, 20, pp.1301~1303 (2014)
56. Mawhood L, "Autism and developmental receptive language disorder--a comparative follow-up in early adult life. I : cognitive and language outcomes", J Child Psychol Psychiatry, 41, pp.547~559 (2000)
57. Nitzan T, "The importance of language delays as an early indicator of subsequent ASD diagnosis in public healthcare settings", J Autism Dev Disord, 53, pp.4535~4544 (2023)
58. Kern JK, "Evidence of neurodegeneration in autism spectrum disorder", Transl Neurodegener, 2, pp.17~ (2013)
59. Zheng Z, "Peripheral blood S100B levels in autism spectrum disorder : a systematic review and metaanalysis", J Autism Dev Disord, 51, pp.2569~2577 (2021)
60. Kjellmer L, "Language and communication skills in preschool children with autism spectrum disorders : contribution of cognition, severity of autism symptoms, and adaptive functioning to the variability", Res Dev Disabil, 33, pp.172~180 (2012)
61. Tan Z, "Serum visinin-like protein 1 is a better biomarker than neuron-specific enolase for seizure-induced neuronal injury : a prospective and observational study", Front Neurol, 11, pp.567587~ (2020)
62. Liu D, "Visinin-like protein-1 level is associated with short-term functional outcome of acute ischemic stroke : a prospective cohort study", Medicine(Baltimore), 99, pp.e19252~ (2020)
63. Hao Y, "Neurodegeneration and glial activation related CSF biomarker as the diagnosis of Alzheimer’s disease : a systematic review and an updated meta-analysis", Curr Alzheimer Res, 19, pp.32~46 (2022)

관련 논문AI추천